AU539494B2 - Interferon proteins + method for producing same - Google Patents

Interferon proteins + method for producing same

Info

Publication number
AU539494B2
AU539494B2 AU57599/80A AU5759980A AU539494B2 AU 539494 B2 AU539494 B2 AU 539494B2 AU 57599/80 A AU57599/80 A AU 57599/80A AU 5759980 A AU5759980 A AU 5759980A AU 539494 B2 AU539494 B2 AU 539494B2
Authority
AU
Australia
Prior art keywords
interferon
protein
human
proteins
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU57599/80A
Other languages
English (en)
Other versions
AU5759980A (en
Inventor
Kurt Frimann Berg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD International Holdings GmbH
Original Assignee
Alfred Benzon AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27220922&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU539494(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alfred Benzon AS filed Critical Alfred Benzon AS
Publication of AU5759980A publication Critical patent/AU5759980A/en
Application granted granted Critical
Publication of AU539494B2 publication Critical patent/AU539494B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU57599/80A 1979-04-20 1980-04-18 Interferon proteins + method for producing same Ceased AU539494B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK164579 1979-04-20
DK164579 1979-04-20
DK79180 1980-02-22
DK79180 1980-02-22
DK148480 1980-04-02
DK148480 1980-04-02

Publications (2)

Publication Number Publication Date
AU5759980A AU5759980A (en) 1980-10-23
AU539494B2 true AU539494B2 (en) 1984-10-04

Family

ID=27220922

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57599/80A Ceased AU539494B2 (en) 1979-04-20 1980-04-18 Interferon proteins + method for producing same

Country Status (15)

Country Link
EP (2) EP0091543B1 (enExample)
JP (2) JPH0742317B2 (enExample)
AU (1) AU539494B2 (enExample)
CA (1) CA1168151A (enExample)
DE (2) DE3072134D1 (enExample)
ES (1) ES8103976A1 (enExample)
FI (1) FI77877C (enExample)
HK (1) HK22792A (enExample)
IE (1) IE55791B1 (enExample)
IL (1) IL59880A (enExample)
NO (1) NO165961C (enExample)
NZ (1) NZ193487A (enExample)
PT (1) PT71111A (enExample)
SG (1) SG92591G (enExample)
WO (1) WO1980002229A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU575304B2 (en) * 1982-11-01 1988-07-28 Genentech Inc. Removal of impurities from human leukocyte interferon

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US6835557B1 (en) 1980-01-08 2004-12-28 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
DK170476B1 (da) 1980-04-03 1995-09-11 Biogen Inc Rekombinant DNA-molekyle, uni-cellulær vært transformeret med mindst ét rekombinant DNA-molekyle, fremgangsmåde til transformering af en uni-cellulær vært, samt fremgangsmåder til fremstilling af et polpeptid, der udviser den immunologiske eller biologiske aktivitet af human beta-interferon
EP0050129B1 (en) * 1980-04-11 1992-03-18 Celltech Limited Monoclonal antibody
CH651308A5 (de) * 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
FR2492842A1 (fr) * 1980-10-24 1982-04-30 Centre Nat Rech Scient Hybride cellulaire produisant un anticorps specifique de l'interferon leucocytaire humain et procede de formation d'hybrides cellulaires producteurs d'anticorps specifiques de l'interferon humain
JPS58500037A (ja) * 1980-11-07 1983-01-06 セルテク　リミテツド インタ−フェロンの検定法
EP0064063B1 (en) * 1980-11-07 1985-09-11 Celltech Limited Assay for interferon
FR2500754B1 (fr) * 1981-02-27 1986-06-27 Hoffmann La Roche Anticorps monoclonaux
DE3280127D1 (de) * 1981-03-27 1990-04-12 Ici Plc Genetisch modifizierte mikroorganismen.
IL65475A0 (en) * 1981-04-17 1982-07-30 Meloy Lab Production of immune interferon and its mrna
EP0085693A1 (en) * 1981-08-14 1983-08-17 A/S Alfred Benzon Subjects relating to human inteferon-alpha subtype proteins and corresponding antibodies
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
US6432677B1 (en) 1982-03-08 2002-08-13 Genentech, Inc. Non-human animal interferons
JPS58201794A (ja) * 1982-05-17 1983-11-24 Toray Ind Inc ヒトインターフェロンβの濃縮精製法
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
DE3306060A1 (de) * 1983-02-22 1984-08-23 Boehringer Ingelheim International GmbH, 6507 Ingelheim Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
EP0490233A1 (de) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
DE3633323A1 (de) * 1986-10-01 1988-04-07 Boehringer Ingelheim Int Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega
SE468251B (sv) 1989-06-20 1992-11-30 Bionative Ab Reningsprocess foer interferon
US5391713A (en) * 1989-06-20 1995-02-21 Bionative Ab Interferon purification process
US5503828A (en) * 1992-02-10 1996-04-02 Interferon Sciences, Inc. Alpha interferon composition and method for its production from human peripheral blood leukocytes
US5676942A (en) * 1992-02-10 1997-10-14 Interferon Sciences, Inc. Composition containing human alpha interferon species proteins and method for use thereof
JP4706093B2 (ja) * 2000-09-25 2011-06-22 富士レビオ株式会社 パルボウイルスの除去方法及び精製方法
US7087726B2 (en) 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2351665A1 (fr) * 1976-05-21 1977-12-16 Elf Aquitaine Procede de purification de preparations possedant notamment une activite interferon, preparations purifiees ainsi obtenues et leur application en tant que medicament
NL7703281A (nl) * 1977-03-25 1978-09-27 Stichting Rega V Z W Werkwijze voor het bereiden van interferon.
FR2389380B1 (enExample) * 1977-05-02 1980-02-29 Anvar
IN150740B (enExample) * 1978-11-24 1982-12-04 Hoffmann La Roche
IE54096B1 (en) * 1980-01-08 1989-06-21 Biogen Nv Dn sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU575304B2 (en) * 1982-11-01 1988-07-28 Genentech Inc. Removal of impurities from human leukocyte interferon

Also Published As

Publication number Publication date
IE800796L (en) 1980-10-20
DE91543T1 (de) 1984-12-20
CA1168151A (en) 1984-05-29
PT71111A (en) 1980-05-01
EP0091543B1 (en) 1989-06-14
AU5759980A (en) 1980-10-23
EP0018218B1 (en) 1988-11-23
JPH0794480B2 (ja) 1995-10-11
SG92591G (en) 1993-02-19
NO801133L (no) 1980-12-18
NZ193487A (en) 1983-07-15
JPH0742317B2 (ja) 1995-05-10
ES490697A0 (es) 1981-04-16
IE55791B1 (en) 1991-01-16
FI77877C (fi) 1989-05-10
FI77877B (fi) 1989-01-31
IL59880A0 (en) 1980-06-30
JPS56500536A (enExample) 1981-04-23
ES8103976A1 (es) 1981-04-16
WO1980002229A1 (en) 1980-10-30
FI801215A7 (fi) 1980-10-21
EP0091543A1 (en) 1983-10-19
EP0018218A1 (en) 1980-10-29
JPH02198A (ja) 1990-01-05
HK22792A (en) 1992-04-03
NO165961B (no) 1991-01-28
NO165961C (no) 1991-05-15
DE3072134D1 (en) 1988-12-29
IL59880A (en) 1984-03-30

Similar Documents

Publication Publication Date Title
AU5759980A (en) Interferon proteins + method for producing same
AU534769B2 (en) Method
AU533096B2 (en) Method
AU529947B2 (en) Method
AU531547B2 (en) Method
AU539791B2 (en) Method
AU531350B2 (en) Method
AU543159B2 (en) Method
AU6231980A (en) Method
AU7246281A (en) Interferons and process for their preparation
AU6194080A (en) Method
AU6166380A (en) Method
AU6191780A (en) Method
AU539025B2 (en) Method
AU539149B2 (en) Method
AU5520380A (en) Method
AU5900980A (en) Method
AU6165480A (en) Method
AU5820480A (en) Method
AU6237180A (en) Method
AU535826B2 (en) Method
AU546195B2 (en) Method
AU6171480A (en) Method
AU6216780A (en) Method
AU6191880A (en) Method